Previous 10 | Next 10 |
Summary CONMED Corporation had a reasonable growth quarter with upsides in key markets. Orthopedics is certainly an exciting growth area and offers leverage with each additional gain in market share. We'd like more time to assess any changes before pulling the trigger on CONMED Corp...
Zimmer Biomet to Present at the 34th Annual Piper Sandler Healthcare Conference PR Newswire WARSAW, Ind. , Nov. 21, 2022 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of ...
Zimmer Biomet Expands Persona® Knee System Portfolio with FDA Clearance of Persona® OsseoTi® Keel Tibia for Cementless Knee Replacement PR Newswire -- New Porous Iteration of Anatomic Keeled Tibia Designed to Deliver Stable Initial and Biological Fixatio...
Summary ZimVie Inc. was spun out of Zimmer Biomet in early March. After a stock plunge that has halved the stock's valuation, ZimVie once again screens attractive on both P/E and P/CF metrics. The September selloff appears to have been caused by Zimmer Biomet pledging its ZimV...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify . For further details see: Wall Street Breakfast: The Week Ahead
Zimmer Biomet Announces One-Year Data from mymobility® Clinical Study at 2022 AAHKS Annual Meeting PR Newswire One-Year Results Reinforce Interim Findings: mymobility Remote Care Management Platform on Apple Watch and iPhone Yielded Similar Outcomes as Tradit...
Zimmer Biomet Holdings, Inc. (ZBH) Q3 2022 Earnings Conference Call November 02, 2022 08:30 AM ET Company Participants Keri Mattox - Senior Vice President, Chief Communications & Administration Officer Bryan Hanson - Chairman, President & Chief Executive Offi...
Zimmer Biomet press release ( NYSE: ZBH ): Q3 Non-GAAP EPS of $1.58 beats by $0.02 . Revenue of $1.67B (-1.2% Y/Y) beats by $30M . Company updates 2022 financial guidance, raising range for full year outlook : 2022 Reported Revenue Change of 0% - 1.0% vs. e...
Zimmer Biomet Announces Third Quarter 2022 Financial Results PR Newswire Third quarter net sales from continuing operations of $1.670 billion decreased 0.9% and increased 5.0% on a constant currency 1 basis Third quarter diluted earnings per share from cont...
Summary Baxter International has had a rough year or so, with shares declining far more than the market has. Some of this was justified by the company's high share price and weakening fundamentals. But given where shares are today, the firm does seem to offer some upside for i...
News, Short Squeeze, Breakout and More Instantly...
Zimmer Biomet Holdings Inc. Company Name:
ZBH Stock Symbol:
NYSE Market:
Zimmer Biomet Holdings Inc. Website:
2024-07-15 16:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2024 Financial Results PR Newswire WARSAW, Ind. , July 8, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its second quarter earnings conference call will ...
Zimmer Biomet Announces Appointment of Devdatt Kurdikar to Board of Directors PR Newswire WARSAW, Ind. , June 20, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Devdatt "Dev" Kurdika...